Halozyme Therapeutics: A Drug Delivery Innovator Reshaping Biopharma Pioneering Subcutaneous Drug Delivery with ENHANZE®Halozyme’s defining innovation lies in its ENHANZE® platform, based on the recombinant human enzyme rHuPH20. This technology enables the transformation of IV biologics into subcutaneous injections, offering shorter administration times and greater patient comfort. ENHANZE® is w..
